Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip J Stephens

Showing results (101-110 of 168) with videos related to

Pageof 17
Sort By:
The Oncologist|March 16, 2018
Hybrid Capture-Based Comprehensive Genomic Profiling Identifies Lung Cancer Patients with Well-Characterized Sensitizing Epidermal Growth Factor Receptor Point Mutations That Were Not Detected by Standard of Care TestingJames H Suh, Alexa B Schrock, Adrienne Johnson, et al.
Oncotarget|May 10, 2014
Unique molecular signatures as a hallmark of patients with metastatic breast cancer: implications for current treatment paradigmsJennifer J Wheler, Barbara A Parker, Jack J Lee, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 2, 2016
HER2 Transmembrane Domain (TMD) Mutations (V659/G660) That Stabilize Homo- and Heterodimerization Are Rare Oncogenic Drivers in Lung Adenocarcinoma That Respond to AfatinibSai-Hong Ignatius Ou, Alexa B Schrock, Eduard V Bocharov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2016
Integrated Analysis of Multiple Biomarkers from Circulating Tumor Cells Enabled by Exclusion-Based Analyte IsolationJamie M Sperger, Lindsay N Strotman, Allison Welsh, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 26, 2016
Characterization of 298 Patients with Lung Cancer Harboring MET Exon 14 Skipping AlterationsAlexa B Schrock, Garrett M Frampton, James Suh, et al.
Oncotarget|April 21, 2017
Clinical genomic profiling to identify actionable alterations for investigational therapies in patients with diverse sarcomasRoman Groisberg, David S Hong, Vijaykumar Holla, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 27, 2013
Advanced urothelial carcinoma: next-generation sequencing reveals diverse genomic alterations and targets of therapyJeffrey S Ross, Kai Wang, Rami N Al-Rohil, et al.
European Urology|June 9, 2017
Characterization of Clinical Cases of Advanced Papillary Renal Cell Carcinoma via Comprehensive Genomic ProfilingSumanta K Pal, Siraj M Ali, Evgeny Yakirevich, et al.
Nature Medicine|April 24, 2019
Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT studyJason K Sicklick, Shumei Kato, Ryosuke Okamura, et al.
The Oncologist|December 17, 2015
Comprehensive Genomic Profiling of Advanced Penile Carcinoma Suggests a High Frequency of Clinically Relevant Genomic AlterationsSiraj M Ali, Sumanta K Pal, Kai Wang, et al.
Pageof 17

Showing results (101-110 of 168) with videos related to

Sort By:
Pageof 17
The Oncologist|March 16, 2018
Hybrid Capture-Based Comprehensive Genomic Profiling Identifies Lung Cancer Patients with Well-Characterized Sensitizing Epidermal Growth Factor Receptor Point Mutations That Were Not Detected by Standard of Care TestingJames H Suh, Alexa B Schrock, Adrienne Johnson, et al.
Oncotarget|May 10, 2014
Unique molecular signatures as a hallmark of patients with metastatic breast cancer: implications for current treatment paradigmsJennifer J Wheler, Barbara A Parker, Jack J Lee, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 2, 2016
HER2 Transmembrane Domain (TMD) Mutations (V659/G660) That Stabilize Homo- and Heterodimerization Are Rare Oncogenic Drivers in Lung Adenocarcinoma That Respond to AfatinibSai-Hong Ignatius Ou, Alexa B Schrock, Eduard V Bocharov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2016
Integrated Analysis of Multiple Biomarkers from Circulating Tumor Cells Enabled by Exclusion-Based Analyte IsolationJamie M Sperger, Lindsay N Strotman, Allison Welsh, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 26, 2016
Characterization of 298 Patients with Lung Cancer Harboring MET Exon 14 Skipping AlterationsAlexa B Schrock, Garrett M Frampton, James Suh, et al.
Oncotarget|April 21, 2017
Clinical genomic profiling to identify actionable alterations for investigational therapies in patients with diverse sarcomasRoman Groisberg, David S Hong, Vijaykumar Holla, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 27, 2013
Advanced urothelial carcinoma: next-generation sequencing reveals diverse genomic alterations and targets of therapyJeffrey S Ross, Kai Wang, Rami N Al-Rohil, et al.
European Urology|June 9, 2017
Characterization of Clinical Cases of Advanced Papillary Renal Cell Carcinoma via Comprehensive Genomic ProfilingSumanta K Pal, Siraj M Ali, Evgeny Yakirevich, et al.
Nature Medicine|April 24, 2019
Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT studyJason K Sicklick, Shumei Kato, Ryosuke Okamura, et al.
The Oncologist|December 17, 2015
Comprehensive Genomic Profiling of Advanced Penile Carcinoma Suggests a High Frequency of Clinically Relevant Genomic AlterationsSiraj M Ali, Sumanta K Pal, Kai Wang, et al.
Pageof 17